Á lódáil...
Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors
A significant unmet need for patients with multiple sclerosis (MS) is the lack of U.S. Food and Drug Administration (FDA)-approved remyelinating therapies. We have identified a compelling remyelinating agent, bazedoxifene (BZA), a European Medicines Agency (EMA)-approved (and FDA-approved in combina...
Na minha lista:
| Foilsithe in: | J Neurosci |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Society for Neuroscience
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6433770/ https://ncbi.nlm.nih.gov/pubmed/30696729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.1530-18.2019 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|